BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 184 filers reported holding BRIDGEBIO PHARMA INC in Q3 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,507,204 | -91.0% | 57,156 | -94.2% | 0.01% | -90.3% |
Q2 2023 | $16,818,367 | -62.5% | 977,812 | -63.8% | 0.10% | -65.0% |
Q1 2023 | $44,838,521 | +58.2% | 2,704,374 | -27.3% | 0.29% | +48.5% |
Q4 2022 | $28,347,048 | -23.3% | 3,720,085 | +0.0% | 0.20% | -26.4% |
Q3 2022 | $36,974,000 | +9.5% | 3,719,666 | +0.0% | 0.27% | +18.0% |
Q2 2022 | $33,769,000 | -10.6% | 3,718,964 | -0.1% | 0.23% | +10.1% |
Q1 2022 | $37,786,000 | -39.2% | 3,722,680 | -0.1% | 0.21% | -33.4% |
Q4 2021 | $62,157,000 | -64.4% | 3,726,388 | -0.1% | 0.31% | -66.6% |
Q3 2021 | $174,774,000 | -23.1% | 3,728,904 | -0.0% | 0.93% | +21.0% |
Q2 2021 | $227,399,000 | -0.9% | 3,730,302 | +0.1% | 0.77% | -4.3% |
Q1 2021 | $229,450,000 | -3.5% | 3,724,834 | +11.4% | 0.80% | -8.6% |
Q4 2020 | $237,673,000 | +29.5% | 3,342,334 | -40.5% | 0.88% | +0.1% |
Q3 2020 | $183,480,000 | +0.1% | 5,619,928 | -0.0% | 0.88% | -0.5% |
Q2 2020 | $183,298,000 | +6.8% | 5,620,919 | -5.0% | 0.88% | -6.0% |
Q1 2020 | $171,658,000 | -27.4% | 5,919,246 | -12.2% | 0.94% | +3.0% |
Q4 2019 | $236,391,000 | +63.2% | 6,744,392 | -0.0% | 0.91% | +56.3% |
Q3 2019 | $144,847,000 | -20.2% | 6,746,511 | +0.2% | 0.58% | -17.6% |
Q2 2019 | $181,569,000 | – | 6,732,244 | – | 0.71% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 3,835,722 | $103,449,000 | 44.18% |
Kohlberg Kravis Roberts & Co. L.P. | 36,900,661 | $995,211,000 | 12.26% |
SC US (TTGP), LTD. | 2,544,738 | $68,632,000 | 4.69% |
Cormorant Asset Management, LP | 2,780,885 | $75,000,000 | 4.31% |
Perceptive Advisors | 6,706,268 | $180,868,000 | 4.15% |
VIKING GLOBAL INVESTORS LP | 26,620,991 | $717,968,000 | 3.22% |
Hillhouse Capital Management | 2,035,790 | $54,905,000 | 1.75% |
Alpine Group USVI, LLC | 20,000 | $539,000 | 1.70% |
HHLR ADVISORS, LTD. | 2,352,900 | $63,458,000 | 1.42% |
SCGE MANAGEMENT, L.P. | 588,235 | $15,865,000 | 0.79% |